Our Businesses
Our Company
For the last 10 years, Johnson & Johnson Innovation has been on a mission to accelerate early-stage innovation aimed at advancing healthcare. As digital technology external innovation lead, Varun Ramdevan looks for the best ideas—and helps make them a reality.
The key to slowing cognitive decline is diagnosing the disease as early as possible. And that's exactly what Johnson & Johnson scientists are relentlessly pursuing.
Advancing drug discovery. Helping treatments reach patients faster. Diversifying clinical trials. Here's a look at how Johnson & Johnson is harnessing AI to help create a healthier world.
The goal of precision medicine is to develop individualized treatments based on a patient's genetic profile. Here's how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.
Nina Raver-Shapira, Ph.D., loves a challenge: The Johnson & Johnson scientist persisted for years to develop an innovative surgical patch that helps stop problematic bleeding during surgery—and she's also a record-breaking elite athlete. For Women’s Equality Day, find out how she got her start, what achievements she’s most proud of and where she finds inspiration.
For World Lung Cancer Day, learn about one patient's journey toward getting an accurate diagnosis—and why it's crucial to always advocate for your health.
Check out this infographic breakdown of the company’s second-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
The goal to eliminate prostate cancer starts with getting people to talk about it—especially Black men, who are two times more likely to die from the disease than most other men. For Prostate Cancer Awareness Month, we spoke with a physician about building awareness and normalizing tough conversations.
We Believe Health is Everything
At Johnson & Johnson, we’re innovating across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow.
-
What You're Talking About
-
Fact
This Johnson & Johnson scientist's cancer diagnosis at age 13 inspired him to pursue a career working on therapies for blood cancer.
